Cardiology – Page 39

ADVANTAGE AF Phase 2: Evaluating Pulsed Field Ablation for Persistent Atrial Fibrillation Using Continuous ECG Monitoring

By MedXY 08/17/2025

The ADVANTAGE AF Phase 2 study demonstrates pulsed field ablation's safety and efficacy for persistent atrial fibrillation, introducing continuous cardiac monitoring to better assess arrhythmia burden and outcomes over one year.

Cardiology news Specialties

Optimizing Sedation for Pulsed-Field Ablation in Atrial Fibrillation: Results of the COOPERATIVE-PFA Trial

By MedXY 08/17/2025

This randomized trial compares sedation regimens for pulsed-field ablation in atrial fibrillation, finding remimazolam-ketamine deep analgosedation superior to propofol-opioid approaches in reducing hypoxemia and hypotension.

Cardiology Clinical Updates news Specialties

High-Dose Statins and Their Impact on the Progression of Small Abdominal Aortic Aneurysms: Insights from a 5-Year Danish Cohort Study

By MedXY 08/17/2025

This 5-year prospective cohort study reveals that high-dose statin therapy significantly slows abdominal aortic aneurysm growth and reduces the risks of repair, rupture, and death in men, suggesting benefits beyond traditional cardiovascular risk management.

Cardiology Clinical Updates news Specialties

Abelacimab vs. Rivaroxaban in Atrial Fibrillation Patients on Antiplatelet Therapy: Insights from the AZALEA-TIMI 71 Trial

By MedXY 08/16/2025

The AZALEA-TIMI 71 trial shows abelacimab, a novel factor XI inhibitor, reduces bleeding risk compared to rivaroxaban in atrial fibrillation patients on antiplatelet therapy, suggesting a safer anticoagulation alternative.

Cardiology Clinical Updates news Specialties

High-Risk Plaques in Non-Culprit Lesions: Comparative Outcomes After NSTEMI and STEMI

By MedXY 08/16/2025

This study examines the morphology of high-risk plaques in non-culprit coronary lesions among NSTEMI and STEMI patients and their impact on clinical outcomes, suggesting comparable prevalence of high-risk features but differing plaque characteristics between these groups.

Cardiology news Specialties

Enhancing Cardiovascular Risk Prediction and Outcomes with Coronary CT Angiography: Insights from the PROMISE and SCOT-HEART Trials

By MedXY 08/16/2025

Coronary CTA, guided by clinical risk models and advanced radiomic plaque analysis, improves prediction and prevention of myocardial infarction in patients with new-onset chest pain, particularly in those with low clinical likelihood of coronary artery disease.

Cardiology Diabetes & Endocrinology Nephrology Specialties

Semaglutide’s Impact on Cardiovascular Outcomes Across Chronic Kidney Disease Stages in Type 2 Diabetes: Insights from the FLOW Trial

By MedXY 08/16/2025

The FLOW trial demonstrates that semaglutide significantly lowers cardiovascular risks and mortality in type 2 diabetes patients with chronic kidney disease, independently of CKD severity.

Cardiology Clinical Updates news Radiology Specialties

Revolutionizing Acute Myocardial Infarction Diagnosis: Insights from a New Clinical Classification Using Cardiac Imaging

By MedXY 08/16/2025

A novel clinical classification incorporating cardiac imaging refines diagnosis of acute myocardial infarction, distinguishing spontaneous, secondary, and non-infarction cases, improving risk stratification and guiding targeted treatment.

Cardiology OB/GYN & Women's Health Specialties

Pregnancies Following Peri-Partum Cardiomyopathy: Insights from the ESC EuroObservational Research Programme

By MedXY 08/16/2025

This study analyses maternal and neonatal outcomes in subsequent pregnancies after peri-partum cardiomyopathy (PPCM), revealing lower than expected maternal risks and suggesting potential reclassification of pregnancy risk categories based on ventricular function.

AI Cardiology Specialties

Advancing Acute Coronary Syndrome Care: ECG-Based Machine Learning Enhances Risk Stratification

By MedXY 08/16/2025

A prospective study shows that machine learning models trained on 12-lead ECG features outperform HEART score in predicting mortality among chest pain patients, improving risk-based care precision.

Cardiology Critical Care news Specialties

C-Reactive Protein as a Prognostic Biomarker in Infarct-Related Cardiogenic Shock: Insights from the ECLS-SHOCK Trial

By MedXY 08/16/2025

Elevated CRP levels independently predict short-term mortality in acute myocardial infarction complicated by cardiogenic shock, with extracorporeal life support showing no survival benefit regardless of CRP levels or admission timing.

Cardiology news Specialties

Evaluating Low-Dose Carperitide for Acute Heart Failure: Insights from the LASCAR-AHF Trial and Nationwide Outcomes in Japan

By MedXY 08/16/2025

Low-dose carperitide shows no significant benefit on long-term outcomes in acute heart failure, with evidence from randomized and large-scale cohort studies suggesting possible increased short-term risks compared to nitrates.

Cardiology Specialties

Comparative Efficacy of Vascular Closure Strategies After TF-TAVI: Insights from ACCESS-TAVI and CHOICE-CLOSURE Trials

By MedXY 08/16/2025

Recent randomized trials compare suture/plug-based versus suture-only and pure plug-based vascular closure techniques after TF-TAVI, revealing differences in complication rates and hemostasis times.

Cardiology Neurology news Specialties

Timing Matters: Early Intensive Blood Pressure Lowering Improves Outcomes in Acute Intracerebral Haemorrhage （INTERACT Trials）

By MedXY 08/16/2025

Early intensive blood pressure lowering within 3 hours of intracerebral haemorrhage onset improves functional recovery and reduces mortality, emphasizing the critical importance of treatment timing.

Cardiology Family Medicine & Nutrition news Specialties

Healthy Eating for the Planet: Linking Sustainable Diets with Reduced Cardiovascular Risk and Longevity

By MedXY 08/15/2025

Observational evidence from over 13,000 US adults reveals that adherence to the environmentally sustainable EAT-Lancet diet is associated with significantly reduced risks of cardiovascular disease, cardiovascular mortality, and all-cause mortality over nearly 30 years.

AI Cardiology news Specialties

Leveraging AI-Driven Care to Significantly Reduce Heart Failure Readmissions: The Linea Model

By MedXY 08/13/2025

Linea integrates generative AI and high-touch virtual nursing to proactively manage heart failure patients, achieving a 50% reduction in hospital readmissions within 90 days, substantially lowering costs and improving patient outcomes.

Cardiology news Specialties

Anaemia as a Predictor of Iron Dysregulation and Modulator of Empagliflozin Response in Heart Failure with Reduced Ejection Fraction: Insights from the EMPATROPISM-FE Trial

By MedXY 08/13/2025

In patients with heart failure and reduced ejection fraction, anaemia predicts iron homeostasis disruption and influences response to empagliflozin, which increases myocardial iron and improves cardiac function and exercise capacity.

Cardiology Clinical Updates Nephrology news Specialties

Delayed Remote Ischemic Preconditioning Reduces Contrast-Associated Acute Kidney Injury After Coronary Angiography and PCI: Insights from a Randomized Trial

By MedXY 08/13/2025

A multicenter randomized trial demonstrates that delayed remote ischemic preconditioning 24 hours prior to coronary angiography or PCI significantly lowers the incidence of contrast-associated acute kidney injury in high-risk patients.

Cardiology Diabetes & Endocrinology news Specialties

The Long-Term Legacy of Atorvastatin: Insights from the 20-Year ASCOT-Legacy Follow-Up

By MedXY 08/13/2025

The ASCOT-Legacy study shows atorvastatin significantly reduces long-term cardiovascular events and deaths over 20 years in hypertensive patients, supporting early statin initiation for cardiovascular prevention.